PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
19.85%
Revenue growth above 1.5x 9698.HK's 4.88%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-13.84%
Negative gross profit growth while 9698.HK is at 1.73%. Joel Greenblatt would examine cost competitiveness or demand decline.
No Data
No Data available this quarter, please select a different quarter.
-59.70%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-108.82%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-109.50%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-109.50%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-7.24%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-7.18%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-97.47%
Dividend reduction while 9698.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
79.71%
Similar OCF growth to 9698.HK's 72.48%. Walter Schloss would assume comparable operations or industry factors.
78.76%
FCF growth above 1.5x 9698.HK's 36.20%. David Dodd would verify if the firm’s strategic investments yield superior returns.
150.56%
10Y revenue/share CAGR at 50-75% of 9698.HK's 246.88%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
59.04%
5Y revenue/share CAGR under 50% of 9698.HK's 246.88%. Michael Burry would suspect a significant competitive gap or product weakness.
-9.55%
Negative 3Y CAGR while 9698.HK stands at 246.88%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-484.78%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-129.36%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-156.22%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-111.91%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-105.00%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-107.21%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
25.20%
Below 50% of 9698.HK's 238.23%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
13.06%
Below 50% of 9698.HK's 238.23%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
26.50%
Inventory growth of 26.50% while 9698.HK is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
27.12%
Asset growth 1.25-1.5x 9698.HK's 21.33%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
7.42%
Under 50% of 9698.HK's 117.64%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
55.15%
Debt growth far above 9698.HK's 9.12%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
28.41%
SG&A growth well above 9698.HK's 19.97%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.